Literature DB >> 17015230

Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders.

Jennifer A Lee1, James R Lupski.   

Abstract

Genomic disorders are a group of human genetic diseases caused by genomic rearrangements resulting in copy-number variation (CNV) affecting a dosage-sensitive gene or genes critical for normal development or maintenance. These disorders represent a wide range of clinically distinct entities but include many diseases affecting nervous system function. Herein, we review selected neurodevelopmental, neurodegenerative, and psychiatric disorders either known or suggested to be caused by genomic rearrangement and CNV. Further, we emphasize the cause-and-effect relationship between gene CNV and complex disease traits. We also discuss the prevalence and heritability of CNV, the correlation between CNV and higher-order genome architecture, and the heritability of personality, behavioral, and psychiatric traits. We speculate that CNV could underlie a significant proportion of normal human variation including differences in cognitive, behavioral, and psychological features.

Entities:  

Mesh:

Year:  2006        PMID: 17015230     DOI: 10.1016/j.neuron.2006.09.027

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  110 in total

1.  A general mechanism for network-dosage compensation in gene circuits.

Authors:  Murat Acar; Bernardo F Pando; Frances H Arnold; Michael B Elowitz; Alexander van Oudenaarden
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

Review 2.  Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity - but still lots to go.

Authors:  Johannes Hebebrand; Anna-Lena Volckmar; Nadja Knoll; Anke Hinney
Journal:  Obes Facts       Date:  2010-10-15       Impact factor: 3.942

3.  Germ-line DNA copy number variation frequencies in a large North American population.

Authors:  George Zogopoulos; Kevin C H Ha; Faisal Naqib; Sara Moore; Hyeja Kim; Alexandre Montpetit; Frederick Robidoux; Philippe Laflamme; Michelle Cotterchio; Celia Greenwood; Stephen W Scherer; Brent Zanke; Thomas J Hudson; Gary D Bader; Steven Gallinger
Journal:  Hum Genet       Date:  2007-07-19       Impact factor: 4.132

4.  A whole genome association study of neuroticism using DNA pooling.

Authors:  S Shifman; A Bhomra; S Smiley; N R Wray; M R James; N G Martin; J M Hettema; S S An; M C Neale; E J C G van den Oord; K S Kendler; X Chen; D I Boomsma; C M Middeldorp; J J Hottenga; P E Slagboom; J Flint
Journal:  Mol Psychiatry       Date:  2007-07-31       Impact factor: 15.992

5.  Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.

Authors:  Shurong Huang; Rosa Ana Risques; George M Martin; Peter S Rabinovitch; Junko Oshima
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

6.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Debbie Lombard; Rene Veikondis; Jonathan Carr; Soraya Bardien
Journal:  Neurogenetics       Date:  2009-12-15       Impact factor: 2.660

7.  Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.

Authors:  Guia Guffanti; Federica Torri; Jerod Rasmussen; Andrew P Clark; Anita Lakatos; Jessica A Turner; James H Fallon; Andrew J Saykin; Michael Weiner; Marquis P Vawter; James A Knowles; Steven G Potkin; Fabio Macciardi
Journal:  Genomics       Date:  2013-04-11       Impact factor: 5.736

8.  Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases.

Authors:  Lina Shao; Chad A Shaw; Xin-Yan Lu; Trilochan Sahoo; Carlos A Bacino; Seema R Lalani; Pawel Stankiewicz; Svetlana A Yatsenko; Yinfeng Li; Sarah Neill; Amber N Pursley; A Craig Chinault; Ankita Patel; Arthur L Beaudet; James R Lupski; Sau W Cheung
Journal:  Am J Med Genet A       Date:  2008-09-01       Impact factor: 2.802

9.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

10.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.